Address: Na Strži 65, 140 00 Praha 4,Czech Republic
Tel: +420 261 141 200
Web: http://www.richtergedeon.cz/
Gedeon Richter – Hungarian based company – has been presented at the Czech Republic (and former Czechoslovakia) since 1956, nowadays it is represented by Gedeon Richter Marketing ČR, s.r.o.
In the Czech Republic the company employs more than 100 employees.
Gedeon Richter has registered more than 60 products – brands exclusively Rx for human medicine. The product portfolio consists of own original products, and of licensed products and branded generics. The main therapeutical areas covered are gynecology, neurology and cardiology. The yearly turnover is about € 28m and it represents 1.30% market share in terms of value and 2.30% in terms of DOT (days of treatment).
The company is ranked at 21st position (of 220 corporations).
The company actively supports education of healthcare professionals and contributes to the public medical awareness.
Gedeon Richter has registered more than 60 products – brands exclusively Rx for human medicine. The product portfolio consists of own original products, and of licensed products and branded generics.
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern European pharma industry. The business has been present in Czechoslovakia since 1956, and has…
The Director of the State Institute for Drug Control in the Czech Republic highlights the Czech pharmaceutical industry as emancipated and points out their tremendous contribution to employment, export balance,…
The GM of Omega Pharma Czech Republic & Slovakia reveals why the company has to position itself as reliable partner rather than a mere supplier and reviews the 32 percent…
The Czech Minister of Health reviews his achievements in his first two years as minister and elaborates on the National Strategy “Health 2020” implemented in early 2014. He furthermore comments on…
The country president of Novartis Czech Republic explains the strategy that led the affiliate to become the number one pharmaceutical company in the Czech market, highlighting the significance of her…
Michaela Hrdlickova of Biogen elaborates on how it is the industry’s responsibility to educate all stakeholders within the Czech Republic in order to embed a health consciousness in every individual…
The executive director of the American Chamber of Commerce in the Czech Republic discusses measuring the impact that healthcare policy changes have on the healthy life years of Czechs. Furthermore,…
The CEO of CzechInvest elaborates on the significance of the healthcare and life science industry for the Czech Republic’s transition into an industry 4.0. Furthermore, he reviews what the Czech…
The country manager for CSL Behring Czech Republic reviews his tremendous success in the country, averaging 50 percent annual growth since 2011. Furthermore, he explains why the current reimbursement system…
Zentiva is part of the generics business of the Sanofi group and an important player in the European market. Founded in the Czech Republic, it currently operates in fifty markets…
A current lack of transparency in Czech healthcare spending is severely detrimental to all industry stakeholders. However, new synergies between the private and public sectors are helping to clear these murky…
The Dedicated Chair of the Pharmaceutical Committee of the Association of Health Insurance Companies speaks about drug pricing procedures, the partnership with the pharmaceutical industry, as well as her overarching…
The executive director of the Česká asociace farmaceutických firem, the Czech Republic’s generic pharmaceutical association, elaborates on the code of ethics recently implemented and followed by all its members, which…
See our Cookie Privacy Policy Here
